Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

M-144

Supelco

MDAI hydrochloride solution

100 μg/mL in acetonitrile: water (9:1) with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C10H11NO2 · HCl
Número CAS:
132741-81-2
Peso molecular:
213.66
Código UNSPSC:
41116107
NACRES:
NA.24

grau

certified reference material

Nível de qualidade

300

Formulário

liquid

Características

Snap-N-Spike®/Snap-N-Shoot®

embalagem

ampule of 1 mL

fabricante/nome comercial

Cerilliant®

drug control

Narcotic Licence Schedule E (Switzerland)

concentração

100 μg/mL in acetonitrile: water (9:1) with 5% 1 M HCl (as free base)

técnica(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

aplicação(ões)

forensics and toxicology

Formato

single component solution

temperatura de armazenamento

−70°C

cadeia de caracteres SMILES

Cl.NC1Cc2cc3OCOc3cc2C1

InChI

1S/C10H11NO2.ClH/c11-8-1-6-3-9-10(13-5-12-9)4-7(6)2-8;/h3-4,8H,1-2,5,11H2;1H

chave InChI

DEZYWEZDXRXACY-UHFFFAOYSA-N

Descrição geral

MDAI, or 5,6-Methylenedioxy-2-aminoindane, is a new stimulant and club/designer drug with significant cases of abuse reported in Asia, Europe and the US. Sold over the Internet as a “bath salt,” MDAI is a potential successor to mephedrone as the next legal high drug.

Informações legais

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

produto relacionado

Nº do produto
Descrição
Preços

A-050

Amine Mixture-6 solution, 250 μg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-010

(±)-MDA-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-011

(±)-MDMA-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-012

(±)-MDA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-013

(±)-MDMA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-027

(±)-MDA-D5 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-029

(±)-MDMA-D5 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-065

(±)-MDEA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-067

(±)-MDEA-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-068

(±)-MDEA-D5 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-081

(±)-MDEA-D6 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-082

(±)-MDEA-D6 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-102

(±)-MBDB hydrochloride, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

D-161

Dibutylone hydrochloride solution, 1 mg/mL in methanol (as free base), certified reference material, ampule of 1 mL, Cerilliant®

E-129

N-Ethylpentylone hydrochloride solution, 1 mg/mL in methanol (as free base), certified reference material, ampule of 1 mL, Cerilliant®

E-130

N-Ethylpentylone-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 1 mL, Cerilliant®

Pictogramas

FlameExclamation mark
GHS02,GHS07

Palavra indicadora

Danger

Classificações de perigo

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

Código de classe de armazenamento

3 - Flammable liquids

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

55.4 °F - closed cup

Ponto de fulgor (°C)

13 °C - closed cup

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Roland P Archer et al.
Drug testing and analysis, 3(7-8), 505-514 (2011-07-12)
Historically, the appearance of new psychoactive materials (and hence the requirement for new reference standards) has been relatively slow. This position has now changed, with 101 new psychoactive substances reported to EMCDDA-Europol since 2006. The newly reported materials, and associated
Cathal T Gallagher et al.
Human psychopharmacology, 27(2), 106-112 (2012-03-06)
The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely
R Oberlender et al.
The Journal of pharmacology and experimental therapeutics, 255(3), 1098-1106 (1990-12-01)
The stimulus properties of 3,4-methylenedioxymethamphetamine (MDMA)-like compounds were studied in rats trained to discriminate saline from (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine [(+)-MBDB] hydrochloride (7.18 mumol/kg; 1.75 mg/kg), the alpha-ethyl homolog of MDMA. In previous experiments with (+)-MBDB as a test drug, complete substitution was
Laurent Karila et al.
Drug testing and analysis, 3(9), 552-559 (2011-10-01)
Designer drugs belong to a group of legally or illegally produced substances that are structurally and pharmacologically very similar to illicit drugs. In the past, designer drugs were often used during all-night dance parties, but they are now consumed in
M P Johnson et al.
Pharmacology, biochemistry, and behavior, 40(4), 915-922 (1991-12-01)
There is increasing evidence linking dopamine (DA) to the long-term serotonergic (5-HT) neurotoxic effects of certain substituted amphetamines such as 3,4-methylenedioxymethamphetamine (MDMA). The present study was undertaken to examine the importance of DA metabolism, uptake inhibition and release in the
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica